Stocks

Tatva Chintan Pharma IPO gets 4.5 times subscription

PTI New Delhi | Updated on July 16, 2021

The QIBs portion was subscribed 50 per cent, while the non-institutional investors’ category received 1.14 times

 

The initial public offering of Tatva Chintan Pharma Chem witnessed huge investor interest, with the issue getting fully subscribed with hours of opening and finally closing with 4.51 times subscription on day 1 of issue on Friday.

The ₹500-crore IPO received bids for 1.47 crore shares as compared to 32.62 lakh shares on offer. The qualified institutional buyers portionwas subscribed 50 per cent, while the non-institutional investors’ category received 1.14 times and those for retail investors 8.24 times, according to NSE data.

The offer is in a price range of ₹1,073-1,083 a share.

Published on July 16, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.